Renaissance Technologies’s Eton Pharmaceutcials ETON Stock Holding History
Bought
Maintained
Sold
Other funds holding ETON
Renaissance Technologies's ETON Position: Q3 2026 in Review
Renaissance Technologies reduced its Eton Pharmaceutcials (ETON) stake by 72% in Q3 2026, selling an estimated $1.92M and leaving 14,459 shares worth $744K. The position accounts for ﹤0.01% of the portfolio, ranked #2457.
Renaissance Technologies first reported a position in ETON in Q1 2020 and has held it in 16 quarters since. The position peaked at $7.05M in Q3 2025. 162 funds tracked by Wall St. Rank hold ETON as of Q3 2026.
- Renaissance Technologies held 14,459 shares of Eton Pharmaceutcials worth $744K as of Q3 2026.
- Renaissance Technologies sold 37,841 Eton Pharmaceutcials shares in Q3 2026, an estimated $1.92M.
- Eton Pharmaceutcials made up ﹤0.01% of Renaissance Technologies's portfolio in Q3 2026, its #2457 holding.
- Renaissance Technologies first reported a position in Eton Pharmaceutcials in Q1 2020 and has held it in 16 quarters since.
- Renaissance Technologies's Eton Pharmaceutcials position peaked at $7.05M in Q3 2025.
- 162 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2026.
Based on Renaissance Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.